CYTO

Altamira Therapeutics Ltd. [CYTO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CYTO Stock Summary

In the News

CYTO Financial details

Company Rating
-
Market Cap
2.89M
Income
-336.32K
Revenue
1.59M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
16
Optionable
No
Shortable
Yes
Earnings
10 Apr 2024
P/E
-0.09
Forward P/E
-
PEG
0.02
P/S
12.26
P/B
-0.29
P/C
-
P/FCF
-0.35
Quick Ratio
0.06
Current Ratio
0.14
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-11.4
EPS next Y
-
EPS next Q
-
EPS this Y
10.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-36.81%
Revenue last 5Y
-24.74%
Revenue Q/Q
-91.07%
EPS Q/Q
-85.77%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-421%
ROE
-1209%
ROC
3.97%
Gross Margin
-372%
Oper. Margin
-8551%
Profit Margin
-8680%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.61-29.0
52W High
-98.97%
52W Low
-70%
RSI
49
Rel Volume
0.6
Avg Volume
1.21M
Volume
724.3K
Perf Week
179.07%
Perf Month
328.57%
Perf Quarter
-
Perf Half Y
-46.91%
-
-
-
-
Beta
2.536
-
-
Volatility
0.06%, 0.05%
Prev Close
125.65%
Price
0.3
Change
129.1%

Something similar

Top by Market Cap
Same Sector
Check Those
Similar Market Cap